Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardenolides from Erysimum cheiranthoides

Z H Lei1, S Yahara, T Nohara

  • 1Faculty of Pharmaceutical Sciences, Kumamoto University, Japan.

Phytochemistry
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observation of the Singly Cabibbo Suppressed Decay D^{0}→b_{1}(1235)^{-}e^{+}ν_{e} and Evidence for D^{+}→b_{1}(1235)^{0}e^{+}ν_{e}.

Physical review letters·2026
Same author

Precision Measurement of the Branching Fraction of D^{+}→μ^{+}ν_{μ}.

Physical review letters·2025
Same author

Observation of Charmonium h_{c} Radiative Decays to Multiple Light Hadrons and the Tensor State f_{2}(1270).

Physical review letters·2025
Same author

Evidence for Two Excited Ω^{-} Hyperons.

Physical review letters·2025
Same author

Observation of D^{+}→η^{'}μ^{+}ν_{μ} and First Experimental Study of D^{+}→η^{'}ℓ^{+}ν_{ℓ} Decay Dynamics.

Physical review letters·2025
Same author

Study of D_{s}^{+}→f_{0}(980)ρ^{+} and ϕπ^{+} Decays through D_{s}^{+}→π^{+}π^{+}π^{-}π^{0}.

Physical review letters·2025

Researchers identified three novel cardiac glycosides, cheiranthosides I, II, and III, from Erysimum cheiranthoides seeds. These compounds, along with two known cardenolides, expand our understanding of plant-derived cardiovascular agents.

Area of Science:

  • Natural Product Chemistry
  • Pharmacognosy
  • Organic Chemistry

Background:

  • Erysimum cheiranthoides seeds are a known source of bioactive compounds.
  • Cardiac glycosides are a class of compounds with significant pharmacological activity, particularly in cardiovascular medicine.
  • Isolation and characterization of novel natural products are crucial for drug discovery.

Purpose of the Study:

  • To isolate and characterize new cardiac glycosides from Erysimum cheiranthoides seeds.
  • To contribute to the understanding of the chemical diversity of Erysimum species.
  • To identify potential new leads for cardiovascular drug development.

Main Methods:

  • Extraction of secondary metabolites from Erysimum cheiranthoides seeds.
  • Chromatographic techniques (e.g., column chromatography, HPLC) for isolation of compounds.

Related Experiment Videos

  • Spectroscopic methods (e.g., NMR, Mass Spectrometry) for structural elucidation.

    • Main Results:

    • Three new cardiac glycosides, named cheiranthosides I, II, and III, were isolated.
    • The structures were determined as 16 beta-hydroxystrophanthidin (strophadogenin) 3-O-beta-glucopyranosyl-(1-->4)-beta-boiviopyranoside, strophadogenin 3-O-alpha-rhamnopyranosyl-(1-->4)-beta-digitoxopyranoside, and strophanthidin 3-O-alpha-rhamnopyranosyl-(1-->4)-beta-digitoxopyranoside.
    • Two known cardenolides were also identified in the seed extract.

    Conclusions:

    • The chemical investigation of Erysimum cheiranthoides seeds yielded novel cardiac glycosides.
    • The identified compounds represent new additions to the known cardenolide family.
    • Further studies are warranted to evaluate the pharmacological properties of these newly isolated compounds.